Global Head Lice Infestation Drug Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Head Lice Infestation Drug Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.
According to APO Research, The global Head Lice Infestation Drug market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Head Lice Infestation Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Head Lice Infestation Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Head Lice Infestation Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Head Lice Infestation Drug include Bayer, Omega Pharma, Thornton and Ross, Prestige Brands, Perrigo, Actavis, Reckitt Benckier, Tyratech and Shionogi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Head Lice Infestation Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Head Lice Infestation Drug.
The Head Lice Infestation Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Head Lice Infestation Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Bayer
Omega Pharma
Thornton and Ross
Prestige Brands
Perrigo
Actavis
Reckitt Benckier
Tyratech
Shionogi
TecLabs
Arborpharma
Major Pharmaceuticals
Logic Products
Tianren
ParaPRO
Head Lice Infestation Drug segment by Type

Lotion
Creams
Shampoo
Other
Head Lice Infestation Drug segment by Application

Children
Adult
Head Lice Infestation Drug Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Head Lice Infestation Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Head Lice Infestation Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Head Lice Infestation Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Head Lice Infestation Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Head Lice Infestation Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Head Lice Infestation Drug Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Head Lice Infestation Drug Sales Estimates and Forecasts (2019-2030)
1.3 Head Lice Infestation Drug Market by Type
1.3.1 Lotion
1.3.2 Creams
1.3.3 Shampoo
1.3.4 Other
1.4 Global Head Lice Infestation Drug Market Size by Type
1.4.1 Global Head Lice Infestation Drug Market Size Overview by Type (2019-2030)
1.4.2 Global Head Lice Infestation Drug Historic Market Size Review by Type (2019-2024)
1.4.3 Global Head Lice Infestation Drug Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Head Lice Infestation Drug Sales Breakdown by Type (2019-2024)
1.5.2 Europe Head Lice Infestation Drug Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Head Lice Infestation Drug Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Head Lice Infestation Drug Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Head Lice Infestation Drug Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Head Lice Infestation Drug Industry Trends
2.2 Head Lice Infestation Drug Industry Drivers
2.3 Head Lice Infestation Drug Industry Opportunities and Challenges
2.4 Head Lice Infestation Drug Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Head Lice Infestation Drug Revenue (2019-2024)
3.2 Global Top Players by Head Lice Infestation Drug Sales (2019-2024)
3.3 Global Top Players by Head Lice Infestation Drug Price (2019-2024)
3.4 Global Head Lice Infestation Drug Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Head Lice Infestation Drug Key Company Manufacturing Sites & Headquarters
3.6 Global Head Lice Infestation Drug Company, Product Type & Application
3.7 Global Head Lice Infestation Drug Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Head Lice Infestation Drug Market CR5 and HHI
3.8.2 Global Top 5 and 10 Head Lice Infestation Drug Players Market Share by Revenue in 2023
3.8.3 2023 Head Lice Infestation Drug Tier 1, Tier 2, and Tier 3
4 Head Lice Infestation Drug Regional Status and Outlook
4.1 Global Head Lice Infestation Drug Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Head Lice Infestation Drug Historic Market Size by Region
4.2.1 Global Head Lice Infestation Drug Sales in Volume by Region (2019-2024)
4.2.2 Global Head Lice Infestation Drug Sales in Value by Region (2019-2024)
4.2.3 Global Head Lice Infestation Drug Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Head Lice Infestation Drug Forecasted Market Size by Region
4.3.1 Global Head Lice Infestation Drug Sales in Volume by Region (2025-2030)
4.3.2 Global Head Lice Infestation Drug Sales in Value by Region (2025-2030)
4.3.3 Global Head Lice Infestation Drug Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Head Lice Infestation Drug by Application
5.1 Head Lice Infestation Drug Market by Application
5.1.1 Children
5.1.2 Adult
5.2 Global Head Lice Infestation Drug Market Size by Application
5.2.1 Global Head Lice Infestation Drug Market Size Overview by Application (2019-2030)
5.2.2 Global Head Lice Infestation Drug Historic Market Size Review by Application (2019-2024)
5.2.3 Global Head Lice Infestation Drug Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Head Lice Infestation Drug Sales Breakdown by Application (2019-2024)
5.3.2 Europe Head Lice Infestation Drug Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Head Lice Infestation Drug Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Head Lice Infestation Drug Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Head Lice Infestation Drug Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Bayer
6.1.1 Bayer Comapny Information
6.1.2 Bayer Business Overview
6.1.3 Bayer Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Head Lice Infestation Drug Product Portfolio
6.1.5 Bayer Recent Developments
6.2 Omega Pharma
6.2.1 Omega Pharma Comapny Information
6.2.2 Omega Pharma Business Overview
6.2.3 Omega Pharma Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Omega Pharma Head Lice Infestation Drug Product Portfolio
6.2.5 Omega Pharma Recent Developments
6.3 Thornton and Ross
6.3.1 Thornton and Ross Comapny Information
6.3.2 Thornton and Ross Business Overview
6.3.3 Thornton and Ross Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Thornton and Ross Head Lice Infestation Drug Product Portfolio
6.3.5 Thornton and Ross Recent Developments
6.4 Prestige Brands
6.4.1 Prestige Brands Comapny Information
6.4.2 Prestige Brands Business Overview
6.4.3 Prestige Brands Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Prestige Brands Head Lice Infestation Drug Product Portfolio
6.4.5 Prestige Brands Recent Developments
6.5 Perrigo
6.5.1 Perrigo Comapny Information
6.5.2 Perrigo Business Overview
6.5.3 Perrigo Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Perrigo Head Lice Infestation Drug Product Portfolio
6.5.5 Perrigo Recent Developments
6.6 Actavis
6.6.1 Actavis Comapny Information
6.6.2 Actavis Business Overview
6.6.3 Actavis Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Actavis Head Lice Infestation Drug Product Portfolio
6.6.5 Actavis Recent Developments
6.7 Reckitt Benckier
6.7.1 Reckitt Benckier Comapny Information
6.7.2 Reckitt Benckier Business Overview
6.7.3 Reckitt Benckier Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Reckitt Benckier Head Lice Infestation Drug Product Portfolio
6.7.5 Reckitt Benckier Recent Developments
6.8 Tyratech
6.8.1 Tyratech Comapny Information
6.8.2 Tyratech Business Overview
6.8.3 Tyratech Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Tyratech Head Lice Infestation Drug Product Portfolio
6.8.5 Tyratech Recent Developments
6.9 Shionogi
6.9.1 Shionogi Comapny Information
6.9.2 Shionogi Business Overview
6.9.3 Shionogi Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shionogi Head Lice Infestation Drug Product Portfolio
6.9.5 Shionogi Recent Developments
6.10 TecLabs
6.10.1 TecLabs Comapny Information
6.10.2 TecLabs Business Overview
6.10.3 TecLabs Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 TecLabs Head Lice Infestation Drug Product Portfolio
6.10.5 TecLabs Recent Developments
6.11 Arborpharma
6.11.1 Arborpharma Comapny Information
6.11.2 Arborpharma Business Overview
6.11.3 Arborpharma Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Arborpharma Head Lice Infestation Drug Product Portfolio
6.11.5 Arborpharma Recent Developments
6.12 Major Pharmaceuticals
6.12.1 Major Pharmaceuticals Comapny Information
6.12.2 Major Pharmaceuticals Business Overview
6.12.3 Major Pharmaceuticals Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Major Pharmaceuticals Head Lice Infestation Drug Product Portfolio
6.12.5 Major Pharmaceuticals Recent Developments
6.13 Logic Products
6.13.1 Logic Products Comapny Information
6.13.2 Logic Products Business Overview
6.13.3 Logic Products Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Logic Products Head Lice Infestation Drug Product Portfolio
6.13.5 Logic Products Recent Developments
6.14 Tianren
6.14.1 Tianren Comapny Information
6.14.2 Tianren Business Overview
6.14.3 Tianren Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Tianren Head Lice Infestation Drug Product Portfolio
6.14.5 Tianren Recent Developments
6.15 ParaPRO
6.15.1 ParaPRO Comapny Information
6.15.2 ParaPRO Business Overview
6.15.3 ParaPRO Head Lice Infestation Drug Sales, Revenue and Gross Margin (2019-2024)
6.15.4 ParaPRO Head Lice Infestation Drug Product Portfolio
6.15.5 ParaPRO Recent Developments
7 North America by Country
7.1 North America Head Lice Infestation Drug Sales by Country
7.1.1 North America Head Lice Infestation Drug Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Head Lice Infestation Drug Sales by Country (2019-2024)
7.1.3 North America Head Lice Infestation Drug Sales Forecast by Country (2025-2030)
7.2 North America Head Lice Infestation Drug Market Size by Country
7.2.1 North America Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Head Lice Infestation Drug Market Size by Country (2019-2024)
7.2.3 North America Head Lice Infestation Drug Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Head Lice Infestation Drug Sales by Country
8.1.1 Europe Head Lice Infestation Drug Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Head Lice Infestation Drug Sales by Country (2019-2024)
8.1.3 Europe Head Lice Infestation Drug Sales Forecast by Country (2025-2030)
8.2 Europe Head Lice Infestation Drug Market Size by Country
8.2.1 Europe Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Head Lice Infestation Drug Market Size by Country (2019-2024)
8.2.3 Europe Head Lice Infestation Drug Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Head Lice Infestation Drug Sales by Country
9.1.1 Asia-Pacific Head Lice Infestation Drug Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Head Lice Infestation Drug Sales by Country (2019-2024)
9.1.3 Asia-Pacific Head Lice Infestation Drug Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Head Lice Infestation Drug Market Size by Country
9.2.1 Asia-Pacific Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Head Lice Infestation Drug Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Head Lice Infestation Drug Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Head Lice Infestation Drug Sales by Country
10.1.1 Latin America Head Lice Infestation Drug Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Head Lice Infestation Drug Sales by Country (2019-2024)
10.1.3 Latin America Head Lice Infestation Drug Sales Forecast by Country (2025-2030)
10.2 Latin America Head Lice Infestation Drug Market Size by Country
10.2.1 Latin America Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Head Lice Infestation Drug Market Size by Country (2019-2024)
10.2.3 Latin America Head Lice Infestation Drug Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Head Lice Infestation Drug Sales by Country
11.1.1 Middle East and Africa Head Lice Infestation Drug Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Head Lice Infestation Drug Sales by Country (2019-2024)
11.1.3 Middle East and Africa Head Lice Infestation Drug Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Head Lice Infestation Drug Market Size by Country
11.2.1 Middle East and Africa Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Head Lice Infestation Drug Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Head Lice Infestation Drug Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Head Lice Infestation Drug Value Chain Analysis
12.1.1 Head Lice Infestation Drug Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Head Lice Infestation Drug Production Mode & Process
12.2 Head Lice Infestation Drug Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Head Lice Infestation Drug Distributors
12.2.3 Head Lice Infestation Drug Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings